Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DK1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,829
Award facts
- Contract value 100% obligated
- $10,829.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections valued at $10,829.07 with a completion date of November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist used for the treatment of type 2 diabetes, reflecting the federal government's pharmaceutical procurement needs for military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant IDC valued at $999,999,999 with DLA Troop Support Medical running through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent competitively awarded delivery orders across multiple therapeutic domains, positioning it as a critical vendor for federal medical procurement through the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F9DK1?
SPE2DR26F9DK1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9DK1 worth?
The government has obligated $10,829 on SPE2DR26F9DK1.
Is contract SPE2DR26F9DK1 an order under another contract?
Yes. SPE2DR26F9DK1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DK1 competed?
The extent of competition for SPE2DR26F9DK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award